Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
2,468
JPY
|
+2.26%
|
|
+4.53%
|
+7.96%
|
Fiscal Period: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
585,084
|
423,708
|
445,962
|
423,074
|
378,771
|
518,218
|
-
|
-
|
Enterprise Value (EV)
1 |
396,176
|
231,679
|
235,023
|
191,232
|
183,740
|
518,218
|
518,218
|
518,218
|
P/E ratio
|
17.1
x
|
11.5
x
|
18.6
x
|
14.4
x
|
9.76
x
|
14.6
x
|
14.8
x
|
13.3
x
|
Yield
|
1.44%
|
2.03%
|
1.98%
|
2.18%
|
2.55%
|
2.43%
|
2.54%
|
2.57%
|
Capitalization / Revenue
|
0.18
x
|
0.13
x
|
0.14
x
|
0.13
x
|
0.11
x
|
0.15
x
|
0.15
x
|
0.14
x
|
EV / Revenue
|
0.18
x
|
0.13
x
|
0.14
x
|
0.13
x
|
0.11
x
|
0.15
x
|
0.15
x
|
0.14
x
|
EV / EBITDA
|
9.18
x
|
6.25
x
|
8.36
x
|
7.06
x
|
5.95
x
|
8.05
x
|
7.64
x
|
7.07
x
|
EV / FCF
|
13.2
x
|
15.4
x
|
24.4
x
|
11.5
x
|
-16.2
x
|
10.1
x
|
13
x
|
11.9
x
|
FCF Yield
|
7.58%
|
6.51%
|
4.11%
|
8.72%
|
-6.16%
|
9.92%
|
7.67%
|
8.38%
|
Price to Book
|
1.18
x
|
0.85
x
|
0.85
x
|
0.8
x
|
0.67
x
|
0.86
x
|
0.84
x
|
0.79
x
|
Nbr of stocks (in thousands)
|
222,465
|
209,964
|
209,963
|
209,962
|
209,962
|
210,017
|
-
|
-
|
Reference price
2 |
2,630
|
2,018
|
2,124
|
2,015
|
1,804
|
2,468
|
2,468
|
2,468
|
Announcement Date
|
5/15/19
|
5/14/20
|
5/13/21
|
5/13/22
|
5/12/23
|
-
|
-
|
-
|
Fiscal Period: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,181,928
|
3,253,079
|
3,211,125
|
3,290,921
|
3,360,008
|
3,526,906
|
3,561,496
|
3,638,820
|
EBITDA
1 |
63,755
|
67,796
|
53,368
|
59,962
|
63,620
|
64,412
|
67,863
|
73,324
|
EBIT
1 |
49,827
|
53,109
|
38,576
|
45,624
|
48,972
|
48,573
|
51,025
|
57,318
|
Operating Margin
|
1.57%
|
1.63%
|
1.2%
|
1.39%
|
1.46%
|
1.38%
|
1.43%
|
1.58%
|
Earnings before Tax (EBT)
1 |
63,461
|
75,536
|
49,237
|
57,284
|
70,061
|
68,278
|
67,827
|
73,914
|
Net income
1 |
34,359
|
37,968
|
23,926
|
29,423
|
38,806
|
35,698
|
35,677
|
39,344
|
Net margin
|
1.08%
|
1.17%
|
0.75%
|
0.89%
|
1.15%
|
1.01%
|
1%
|
1.08%
|
EPS
2 |
154.1
|
175.8
|
114.0
|
140.1
|
184.8
|
169.4
|
166.6
|
185.5
|
Free Cash Flow
1 |
44,355
|
27,596
|
18,307
|
36,873
|
-23,348
|
51,427
|
39,722
|
43,433
|
FCF margin
|
1.39%
|
0.85%
|
0.57%
|
1.12%
|
-0.69%
|
1.46%
|
1.12%
|
1.19%
|
FCF Conversion (EBITDA)
|
69.57%
|
40.7%
|
34.3%
|
61.49%
|
-
|
79.84%
|
58.53%
|
59.23%
|
FCF Conversion (Net income)
|
129.09%
|
72.68%
|
76.52%
|
125.32%
|
-
|
144.06%
|
111.34%
|
110.39%
|
Dividend per Share
2 |
38.00
|
41.00
|
42.00
|
44.00
|
46.00
|
60.00
|
62.67
|
63.50
|
Announcement Date
|
5/15/19
|
5/14/20
|
5/13/21
|
5/13/22
|
5/12/23
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
1,654,846
|
1,588,418
|
1,622,707
|
818,367
|
1,643,244
|
864,026
|
783,651
|
838,328
|
847,068
|
1,685,396
|
882,022
|
792,590
|
886,737
|
892,252
|
1,778,989
|
935,926
|
839,885
|
903,600
|
912,200
|
948,100
|
862,100
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
27,947
|
18,002
|
20,574
|
10,996
|
24,278
|
12,753
|
8,593
|
13,516
|
12,027
|
25,543
|
11,988
|
11,441
|
12,401
|
8,230
|
20,631
|
16,584
|
11,871
|
13,900
|
12,300
|
15,200
|
12,000
|
Operating Margin
|
1.69%
|
1.13%
|
1.27%
|
1.34%
|
1.48%
|
1.48%
|
1.1%
|
1.61%
|
1.42%
|
1.52%
|
1.36%
|
1.44%
|
1.4%
|
0.92%
|
1.16%
|
1.77%
|
1.41%
|
1.54%
|
1.35%
|
1.6%
|
1.39%
|
Earnings before Tax (EBT)
1 |
32,196
|
24,878
|
24,359
|
16,500
|
33,958
|
18,268
|
5,058
|
17,227
|
16,115
|
33,342
|
23,331
|
-
|
19,963
|
12,877
|
32,840
|
20,885
|
13,305
|
17,800
|
16,300
|
20,000
|
15,200
|
Net income
1 |
16,567
|
11,928
|
11,998
|
9,080
|
18,525
|
10,307
|
591
|
8,270
|
9,054
|
17,324
|
12,524
|
8,958
|
11,188
|
5,966
|
17,154
|
11,132
|
8,878
|
9,400
|
8,700
|
10,900
|
7,700
|
Net margin
|
1%
|
0.75%
|
0.74%
|
1.11%
|
1.13%
|
1.19%
|
0.08%
|
0.99%
|
1.07%
|
1.03%
|
1.42%
|
1.13%
|
1.26%
|
0.67%
|
0.96%
|
1.19%
|
1.06%
|
1.04%
|
0.95%
|
1.15%
|
0.89%
|
EPS
|
74.63
|
56.81
|
-
|
-
|
88.23
|
49.09
|
-
|
39.39
|
-
|
82.51
|
59.65
|
-
|
52.32
|
-
|
80.48
|
52.71
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
20.00
|
21.00
|
-
|
-
|
21.00
|
-
|
-
|
-
|
-
|
23.00
|
-
|
-
|
-
|
-
|
30.00
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/31/19
|
10/30/20
|
5/13/21
|
10/29/21
|
10/29/21
|
2/1/22
|
5/13/22
|
7/29/22
|
10/31/22
|
10/31/22
|
2/1/23
|
5/12/23
|
8/2/23
|
11/2/23
|
11/2/23
|
2/5/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
188,908
|
192,029
|
210,939
|
231,842
|
195,031
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
44,355
|
27,596
|
18,307
|
36,873
|
-23,348
|
51,427
|
39,722
|
43,433
|
ROE (net income / shareholders' equity)
|
7%
|
7.6%
|
4.7%
|
5.6%
|
7.1%
|
6.19%
|
5.95%
|
6.25%
|
ROA (Net income/ Total Assets)
|
3.95%
|
4.17%
|
3.19%
|
3.66%
|
3.82%
|
3.8%
|
2.8%
|
3.9%
|
Assets
1 |
870,743
|
910,460
|
750,784
|
803,650
|
1,017,001
|
939,412
|
1,274,167
|
1,008,821
|
Book Value Per Share
2 |
2,234
|
2,383
|
2,491
|
2,526
|
2,674
|
2,877
|
2,952
|
3,112
|
Cash Flow per Share
2 |
214.0
|
242.0
|
183.0
|
207.0
|
253.0
|
242.0
|
236.0
|
-
|
Capex
1 |
19,361
|
29,321
|
16,141
|
18,150
|
17,434
|
20,217
|
18,578
|
18,578
|
Capex / Sales
|
0.61%
|
0.9%
|
0.5%
|
0.55%
|
0.52%
|
0.57%
|
0.52%
|
0.51%
|
Announcement Date
|
5/15/19
|
5/14/20
|
5/13/21
|
5/13/22
|
5/12/23
|
-
|
-
|
-
|
Last Close Price
2,468
JPY Average target price
2,593
JPY Spread / Average Target +5.10% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.96% | 3.29B | | +17.35% | 71.39B | | +5.38% | 8.59B | | +6.69% | 8.19B | | -20.96% | 7.91B | | +0.49% | 4.54B | | +17.12% | 4.31B | | -3.38% | 3.93B | | -2.61% | 3.86B | | +22.08% | 3.64B |
Pharmaceuticals Wholesale
|